The CDC reports no new cases of infant botulism linked to ByHeart formula.

New Key Finding: As of January 23, 2026, two samples collected by FDA tested positive for Clostridium botulinum type A: One is a ByHeart powdered infant formula closed product sample that matches a clinical isolate from an infant included in this outbreak according to whole






